RadNet, Inc.
RDNT
Updated: 23/09/2026, 13:28:56
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
No summaries found.
- Share price
- $73.93
- Market cap
- $5.81B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Howard G. Berger
- Employees
- 9,060
- IPO date
- 03/01/1997
- Beta
- 1.404
- Last dividend
- $0.00
- Day range
- $73.05 – $74.80
- 52-week range
- $50.82 – $85.84
- 1-day performance
- 1.73%
- 1-year performance
- 45.47%
- Current drawdown (1Y)
- -13.87%
- CIK
- 0000790526
- CUSIP
- 750491102
- ISIN
- US7504911022
- Created
- 07/12/2025, 13:56:32
- Last update
- 23/09/2026, 13:28:56
Track RadNet, Inc. with an AI analyst
See which prediction-market events move RDNT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Is It Too Late to Buy RadNet Inc (RDNT) After 3.5% Rally? GF Value Says Undervalued
GuruFocus • STOCK • 10/06/2026, 22:24:00
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
GlobeNewsWire • STOCK • 10/06/2026, 18:05:00
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
GlobeNewsWire • STOCK • 10/06/2026, 08:00:00
Do Options Traders Know Something About RadNet Stock We Don't?
Zacks Investment Research • STOCK • 02/06/2026, 11:50:38
RadNet to Host Men's Health Webinar on June 13, 2026
GlobeNewsWire • STOCK • 28/05/2026, 08:00:00
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 12/05/2026, 03:10:43
RadNet Q1 Earnings Call Highlights
MarketBeat • STOCK • 11/05/2026, 15:11:11
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
GlobeNewsWire • STOCK • 10/05/2026, 18:05:00
Will RadNet (RDNT) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research • STOCK • 04/05/2026, 13:00:32
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
GlobeNewsWire • STOCK • 28/04/2026, 08:00:00
RadNet Insider Sells 15,000 Shares as Stock Falls 12% in 2026
The Motley Fool • STOCK • 23/03/2026, 16:27:31
RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Seeking Alpha • STOCK • 12/03/2026, 17:12:19